A detailed history of Sound Financial Strategies Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sound Financial Strategies Group, LLC holds 1,238 shares of ABBV stock, worth $241,880. This represents 0.2% of its overall portfolio holdings.

Number of Shares
1,238
Previous 3,784 67.28%
Holding current value
$241,880
Previous $689,000 69.23%
% of portfolio
0.2%
Previous 0.63%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$154.79 - $180.76 $394,095 - $460,214
-2,546 Reduced 67.28%
1,238 $212,000
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $13,105 - $14,932
-82 Reduced 2.12%
3,784 $689,000
Q4 2023

Feb 02, 2024

SELL
$137.6 - $154.97 $271,622 - $305,910
-1,974 Reduced 33.8%
3,866 $599,000
Q3 2023

Nov 06, 2023

SELL
$133.59 - $154.65 $49,695 - $57,529
-372 Reduced 5.99%
5,840 $870,000
Q2 2023

Aug 07, 2023

SELL
$132.51 - $164.9 $48,763 - $60,683
-368 Reduced 5.59%
6,212 $836,000
Q1 2023

May 02, 2023

BUY
$144.61 - $166.54 $554,290 - $638,347
3,833 Added 139.53%
6,580 $1.05 Million
Q4 2022

Jan 30, 2023

BUY
$138.31 - $165.87 $379,937 - $455,644
2,747 New
2,747 $444,000
Q2 2022

Jul 25, 2022

SELL
$137.62 - $174.96 $358,500 - $455,770
-2,605 Reduced 49.53%
2,654 $406,000
Q1 2022

May 05, 2022

SELL
$131.98 - $163.75 $1,451 - $1,801
-11 Reduced 0.21%
5,259 $853,000
Q4 2021

Feb 03, 2022

SELL
$107.43 - $135.93 $15,147 - $19,166
-141 Reduced 2.61%
5,270 $714,000
Q3 2021

Nov 03, 2021

SELL
$106.4 - $120.78 $2,128 - $2,415
-20 Reduced 0.37%
5,411 $584,000
Q2 2021

Jul 30, 2021

SELL
$105.21 - $117.21 $76,172 - $84,860
-724 Reduced 11.76%
5,431 $612,000
Q1 2021

May 07, 2021

SELL
$102.3 - $112.62 $42,659 - $46,962
-417 Reduced 6.35%
6,155 $666,000
Q4 2020

Jan 22, 2021

BUY
$80.49 - $108.67 $528,980 - $714,179
6,572 New
6,572 $704,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $345B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sound Financial Strategies Group, LLC Portfolio

Follow Sound Financial Strategies Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sound Financial Strategies Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sound Financial Strategies Group, LLC with notifications on news.